₹151.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Methorapfs 20 Injection 0.4 ml belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis and severe psoriasis.
Methorapfs 20 Injection 0.4 ml is also used to treat cancer, such as breast cancer, cervical cancer, bladder cancer, ovarian cancer, testicular cancer, lung cancer, head and neck cancer, mycosis fungoides (a type of blood cancer), bone cancer, and advanced-stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system).
Methorapfs 20 Injection 0.4 ml contains 'Methotrexate' that works by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time.
Methorapfs 20 Injection 0.4 ml prevents and stops the growth of cancer cells, thereby helping treat cancer. Methorapfs 20 Injection 0.4 ml treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis.
In some cases, Methorapfs 20 Injection 0.4 ml may cause side effects such as nausea, vomiting, diarrhoea, unusual fatigue, dizziness, headache, loss of appetite, lowered resistance to infections, and tingling sensation. Talk to your doctor if you experience any of the side effects persistently.
Do not take Methorapfs 20 Injection 0.4 ml if you are pregnant or breastfeeding. Inform your doctor about your medications and health condition to rule out any unpleasant side effects.
Methorapfs 20 Injection 0.4 ml is used to treat autoimmune diseases and certain types of cancer. The detailed uses of Methorapfs 20 Injection 0.4 ml are as follows:
Unsafe
You are recommended to avoid alcohol consumption while taking Methorapfs 20 Injection 0.4 ml.
Unsafe
Methorapfs 20 Injection 0.4 ml may cause serious birth defects. It is not recommended to take Methorapfs 20 Injection 0.4 ml while you are pregnant.
Unsafe
Methorapfs 20 Injection 0.4 ml passes into breast milk. Avoid breastfeeding whilst on treatment with Methorapfs 20 Injection 0.4 ml and for at least 1 week after the last dose.
Caution
Methorapfs 20 Injection 0.4 ml may cause dizziness and tiredness; do not drive or operate heavy machinery until you know how Methorapfs 20 Injection 0.4 ml affects you.
Caution
Please consult your doctor if you have liver impairment before receiving Methorapfs 20 Injection 0.4 ml.
Caution
Please consult your doctor if you have kidney impairment before receiving Methorapfs 20 Injection 0.4 ml.
Caution
The efficacy and safety of Methorapfs 20 Injection 0.4 ml in children have been established in polyarticular-course juvenile rheumatoid arthritis and cancer chemotherapy. Please consult your doctor if you have any concerns regarding the usage of Methorapfs 20 Injection 0.4 ml in children.
Caution
Methorapfs 20 Injection 0.4 ml can be used in heart patients and may even provide cardiovascular benefits. However, it should be administered under medical supervision due to potential side effects and drug interactions.
Caution
Methorapfs 20 Injection 0.4 ml can be used in geriatric patients, but with caution due to increased sensitivity to side effects like liver toxicity and bone marrow suppression. Regular monitoring and dose adjustments are essential to ensure safe use.
Arthritis:
Psoriasis:
Cancer:

Have a query?
The time required for Methorapfs 20 Injection 0.4 ml to start to work: Methorapfs 20 Injection 0.4 ml ideally shows its action within 30 to 60 minutes after administration.
The time for which the effects of Methorapfs 20 Injection 0.4 ml last: The effect of Methorapfs 20 Injection 0.4 ml lasts for 9 to 30 hours at a low dose and 24 to 45 hours at a high dose.
Drug-Drug Interactions: Methorapfs 20 Injection 0.4 ml may have interactions with pain killers/NSAIDs, an antineoplastic agent (cisplatin), immunosuppressants (mercaptopurine, azathioprine), antibiotics (tetracycline, chloramphenicol), and anti-inflammatory agents (sulfasalazine), retinoids.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform your doctor if you have immunodeficiency conditions, bone marrow problems, low white blood cell count, low platelet count, serious anaemia, liver problems due to alcohol abuse, or chronic liver disease.
Login/Sign Up
Login/Sign Up
RXIpca Laboratories Ltd
₹152
(₹152.0/ 1ml)
Methorapfs 20 Injection 0.4 ml acts as an immunosuppressant, which helps in reducing inflammation and preventing joint stiffness, thereby providing relief from rheumatoid arthritis.
Methorapfs 20 Injection 0.4 ml works by suppressing the overactive immune system that is responsible for causing psoriasis. Methorapfs 20 Injection 0.4 ml interferes with the synthesis of genetic material (DNA) and the growth of cells that multiply faster than usual, thereby helping in treating psoriasis.
Methorapfs 20 Injection 0.4 ml may affect fertility in men and women. Consult your doctor if you have any concerns regarding this.
Methorapfs 20 Injection 0.4 ml causes leukopenia (decreased number of white blood cells) and hence may make you more susceptible to infections. Consult your doctor if you develop any signs of infection, such as fever, sore throat, breathlessness, jaundice, unexplained bleeding or bruising.
Methorapfs 20 Injection 0.4 ml may make your skin sensitive to sunlight. Therefore, avoid prolonged or unnecessary exposure to sunlight or ultraviolet light, such as tanning beds and sunlamps. Wear protective clothing, sunglasses, and sunscreen while going out.
Methorapfs 20 Injection 0.4 ml works by suppressing the overactive immune system that is responsible for causing psoriasis. Methorapfs 20 Injection 0.4 ml interferes with the synthesis of genetic material (DNA) and the growth of cells that multiply faster than usual, thereby helping in treating psoriasis and psoriatic arthritis.
Disclaimer
We provide you with authentic, trustworthy and relevant information